FDA uses AI, Elsa, to accelerate reviews

forbes.com

The FDA has launched an AI tool, Elsa, to expedite scientific reviews and identify inspection targets, aiming to streamline its processes. Elsa will assist in database creation, information summarization for safety assessments, and pinpointing high-priority inspection targets within the FDA. This initiative reflects the growing integration of AI in government agencies. Meanwhile, academic journals face bot-driven data scraping, and AI companies are shifting focus to model evaluation and specialized data, highlighting evolving AI industry trends.


With a significance score of 4.7, this news ranks in the top 2.8% of today's 26782 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


FDA uses AI, Elsa, to accelerate reviews | News Minimalist